MwanzoSHTDF • OTCMKTS
add
Sinopharm Group Co Ltd
Bei iliyotangulia
$ 2.30
Bei za siku
$ 2.35 - $ 2.35
Bei za mwaka
$ 1.97 - $ 2.94
Thamani ya kampuni katika soko
57.54B HKD
Wastani wa hisa zilizouzwa
132.00
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
HKG
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CNY) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 144.89B | -3.82% |
Matumizi ya uendeshaji wa biashara | 6.44B | 15.96% |
Mapato halisi | 1.67B | -43.43% |
Kiwango cha faida halisi | 1.15 | -41.33% |
Mapato kwa kila hisa | — | — |
EBITDA | 5.32B | -35.75% |
Asilimia ya kodi ya mapato | 29.36% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CNY) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 54.31B | -19.10% |
Jumla ya mali | 392.83B | 2.46% |
Jumla ya dhima | 266.14B | 1.17% |
Jumla ya hisa | 126.69B | — |
hisa zilizosalia | 3.12B | — |
Uwiano wa bei na thamani | 0.09 | — |
Faida inayotokana na mali | 3.00% | — |
Faida inayotokana mtaji | 5.81% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CNY) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 1.67B | -43.43% |
Pesa kutokana na shughuli | 26.27B | 43.57% |
Pesa kutokana na uwekezaji | -1.36B | 69.47% |
Pesa kutokana na ufadhili | -19.42B | -266.23% |
Mabadiliko halisi ya pesa taslimu | 5.49B | -78.50% |
Mtiririko huru wa pesa | 3.14B | -92.00% |
Kuhusu
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Ilianzishwa
2003
Tovuti
Wafanyakazi
108,217
